an early increase in levels of fibrinopeptide a ( p less than .01 ) , fibrinopeptide b beta-15-42 ( p less than .001 ) , and fibrin ( ogen ) degradation products ( p less than .001 ) ;
C0016022
fibrinopeptide a
C0015982
fibrin